EVA STAFFORD: Open Payments
NPI 1982938866 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,353 in 195 payments from 33 companies in 2025. Trend: 2023 $2,922 · 2024 $2,982 · 2025 $3,353
Food & beverage: $3,341Education: $12
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $353 |
| AstraZeneca Pharmaceuticals LP | 12 | $275 |
| PFIZER INC. | 18 | $275 |
| Novo Nordisk Inc | 14 | $231 |
| Lilly USA, LLC | 15 | $217 |
| GlaxoSmithKline, LLC. | 13 | $214 |
| Lundbeck LLC | 8 | $199 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $173 |
| Sumitomo Pharma America, Inc. | 11 | $138 |
| Vanda Pharmaceuticals Inc. | 7 | $136 |
Products named: REXULTI, Kerendia, FARXIGA, NURTEC ODT, VRAYLAR, Wegovy, UBRELVY, TRELEGY ELLIPTA.
Industry payments across LA — which companies pay providers there.
